Martin R. Turner on Neurofilament Light Chain as Prognostic Biomarker in ALS

COMMENT This study adds further weight to CSF NfL as the leading prognostic biomarker in ALS. The extension of the analysis to consider clinical upper and lower motor neuron involvement, regional phenotypes, and the clinical disease stage is interesting, and the ...

Martin R. Turner on Gray matter perfusion correlates with disease severity in ALS.

COMMENT This comment was solicited by the Alzheimer Research Forum. There is a clear need for novel biomarkers that are sensitive to progression of disease in ALS and that could be used to facilitate monitoring in therapeutic trials and reduce the reliance on ...

Current Filters

TYPE: Comment x
Commentator: Turner, Martin R. x

Remove all filters

SEARCH RESULTS

Martin R. Turner on Neurofilament Light Chain as Prognostic Biomarker in ALS

Martin R. Turner on Gray matter perfusion correlates with disease severity in ALS.

Current Filters

Filter By